Business
United Kingdom Dimethyl Isosorbide (DMI) Solvent Market Outlook: Croda International Plc, Roquette Frères, and Ashland
Strong regulatory push, rising demand for sustainable solvents, and advanced formulation needs position the UK as the fastest-growing DMI solvent market
About this update from Croda International Plc
[{"type":"text","content":"Dimethyl Isosorbide (DMI) Solvent Market Strong regulatory push, rising demand for sustainable solvents, and advanced formulation needs position the UK as the fastest-growing DMI solvent market ROCKVILLE, MD, UNITED STATES, April 13, 2026 /EINPresswire.com/ -- According to Fact.MR’s latest analysis, the Dimethyl Isosorbide (DMI) solvent market in the United Kingdom is witnessing accelerated expansion, supported by strong regulatory frameworks and increasing demand for bio-based specialty solvents. Globally valued at USD 198.5 million in 2025, the market is expected to reach USD 212.6 million in 2026 and expand to USD 398.7 million by 2036. Within this landscape, the United Kingdom is projected to grow at a CAGR of 7.1%, outperforming other developed markets. This growth is driven by increasing adoption of environmentally compliant solvents across cosmetics, pharmaceuticals, and specialty chemical formulations, supported by UK REACH regulations and sustainability mandates. Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=14702 Quick Stats (United Kingdom Focus) Global Market Size (2026): USD 212.6 Million Global Forecast Value (2036): USD 398.7 Million United Kingdom CAGR (2026–2036):7.1% Global CAGR: 6.5% Leading Segment: Cosmetics & Personal Care (44% share) Leading Function: Solubilizing Agent (41% share) Key Players in UK Market: Croda International Plc, Roquette Frères, Ashland Global Holdings Inc., Merck KGaA Executive Insight for Decision Makers The UK DMI solvent market reflects a strategic shift toward high-performance, sustainable solvents. Manufacturers must ensure consistent supply of bio-based feedstocks and maintain pharmaceutical-grade purity standards Formulators should focus on improving solubility and penetration efficiency of active ingredients Investors are increasingly prioritizing companies aligned with green chemistry and regulatory compliance Failure to adapt to UK sustainability standards may result in limited market access and competitive disadvantage. Market Dynamics Key Growth Drivers: Strong regulatory push under UK REACH for safer chemical alternatives Rising demand for bio-based solvents in personal care and pharma formulations Growth in advanced skincare and transdermal drug delivery systems Increasing need fo...